Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) FCF Margin (2016)

Historic FCF Margin for Tenax Therapeutics (TENX) over the last 5 years, with Q2 2015 value amounting to 69399.23%.

  • Tenax Therapeutics' FCF Margin changed N/A to 69399.23% in Q2 2015 from the same period last year, while for Mar 2016 it was 375685.5%, marking a year-over-year change of. This contributed to the annual value of 64395.65% for FY2024, which is 397956500.0% up from last year.
  • Per Tenax Therapeutics' latest filing, its FCF Margin stood at 69399.23% for Q2 2015.
  • In the past 5 years, Tenax Therapeutics' FCF Margin registered a high of 69399.23% during Q2 2015, and its lowest value of 49236.2% during Q4 2011.
  • Over the past 4 years, Tenax Therapeutics' median FCF Margin value was 9737.26% (recorded in 2011), while the average stood at 8166.43%.
  • In the last 5 years, Tenax Therapeutics' FCF Margin tumbled by 2000000000bps in 2011 and then soared by 382010700bps in 2012.
  • Tenax Therapeutics' FCF Margin (Quarter) stood at 49236.2% in 2011, then surged by 78bps to 11035.14% in 2012, then surged by 68bps to 3540.98% in 2013, then skyrocketed by 2060bps to 69399.23% in 2015.
  • Its FCF Margin stands at 69399.23% for Q2 2015, versus 3540.98% for Q2 2013 and 25881.82% for Q1 2013.